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Introduction
Hirschsprung’s disease (HSCR) is a congenital disorder of 
dysfunctional enteric nervous system (ENS) development, 
resulting in distal aganglionosis of the bowel.1 The cellular 
composition of the transition zone (TZ), the region between the 
distal aganglionic bowel and normally innervated ganglionic 
bowel, is not well understood. Some children have resectional 
surgery in which TZ bowel is left in situ, with variable effects 
on functional outcome.2 Understanding the cellular anatomy 
of this region may aid in understanding the aetiology of HSCR 
and the effects of TZ pull-through on outcome, in addition to 
permitting the development of safe and effective use of ENS 
progenitor cells as therapy.
This work aimed to characterise the TZ of short-segment 
HSCR bowel, by assessing the expression of ENS and neuronal 
markers by immunofluorescence and quantitative polymerase 
chain reaction (qPCR).
Materials and methods
Human bowel was collected following a pull-through procedure 
in four patients with short-segment HSCR. Protein expression 
of ENS and neuronal markers (p75, SOX10, PHOX2b, Hu 
and GLUT1; Table 1) in ganglionic, proximal and distal TZ 
and aganglionic region of the bowel was visualised through 
immunofluorescence, and mRNA levels of the corresponding 
markers were quantified using qPCR.
Results and discussion
Immunofluorescence analysis showed a gradual loss of SOX10, 
PHOX2b and Hu protein in the lower TZ and absence in the 
aganglionic region. However, generally the expression of ENS 
and neuronal markers presented with inter-patient variability 
within the TZ. In contrast, GLUT1 was highly expressed in the 
perineurium of thickened nerve trunks, characteristic of the 
aganglionic region. Perineurial structures positive for GLUT1 
were also visualised in the TZ, but to a lesser extent than in 
the aganglionic region. This observation corresponded with 
a decrease in mRNA levels of p75, SOX10, PHOX2b and Hu 
from the ganglionic to the aganglionic region and an increase 
in GLUT1.
While SOX10, PHOX2b and Hu positivity was not observed 
by immunofluorescence in the aganglionic region of bowel, 
mRNA of each marker was detected at low levels in each 
region via qPCR. Immunofluorescence visually detects protein 
expression, while qPCR quantifies mRNA levels. As mRNA is 
eventually transcribed into a protein, it may be assumed that 
there is a correlation between mRNA and protein levels, with 
qPCR and immunofluorescence results complementing each 
other. However, due to the many complicated and varied post-
transcriptional mechanisms involved in protein production 
from mRNA, there is potential for poor correlation between 
mRNA and protein expression, hence the potential for 
differing results between the methods.3
Conclusion
This work displayed a trend of a decreasing number of cells 
expressing ENS and neuronal markers from the ganglionic and 
aganglionic region, through the TZ. However, our analysis reveals 
inter-patient variability in the cellular composition of HSCR 
bowel, especially in the TZ. This finding may explain the variable 
functional outcome for HSCR children with TZ pull-through. n
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Table 1. Neuronal markers studied in different 





GLUT1 Glucose transporter and expressed in 
perineurium of nerves
Hu Human neuronal marker
SOX10 ENCC and glial cell marker
PHOX2b ENCC and neural cell marker
ENCC = enteric neural crest cell.
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